Scientific Beta

Today UK News: "Again, the point of ESG is not to outperform the market. Just as well. As recently reported in the Financial Times [search result]: “There is no ESG alpha,” said Felix Goltz, research director at Scientific Beta and co-author of the as yet unpublished paper, Honey, I Shrunk the ESG Alpha. “The claims of positive alpha in popular industry publications are not valid because the analysis underlying these claims is flawed,” with analytical errors “enabling the documenting of outperformance where in reality there is none”, he added."

Today UK News 21/06/2021

"(...) Again, the point of ESG is not to outperform the market. Just as well. As recently reported in the Financial Times [search result]: “There is no ESG alpha,” said Felix Goltz, research director at Scientific Beta and co-author of the as yet unpublished paper, Honey, I Shrunk the ESG Alpha. “The claims of positive alpha in popular industry publications are not valid because the analysis underlying these claims is flawed,” with analytical errors “enabling the documenting of outperformance where in reality there is none”, he added. Financial Times, 3 May 2021. Deciding to invest by considering ESG scoring should instead be a decision to allocate capital towards companies that do ‘good’. (...)"